Related Experiment Video
Updated: Oct 22, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
Ronny Alcalai1,2, Michael Arad3, Hiroko Wakimoto2
1Heart InstituteHadassah Hebrew University Medical Center Jerusalem Israel.
Insights
A LAMP2 gene mutation causes Danon disease cardiomyopathy in mice, leading to heart failure, arrhythmias, and cellular damage due to impaired autophagy.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Human mutations in the X-linked lysosome-associated membrane protein-2 (LAMP2) gene cause Danon disease, a condition characterized by cardiac hypertrophy, conduction abnormalities, and arrhythmias.
- A specific in-frame exon 6 deletion (L2Δ6) in the LAMP2 gene is linked to human cardiomyopathy.
Purpose of the Study:
- To investigate the consequences of the L2Δ6 mutation on cardiomyocyte biology and cardiac function in a mouse model.
- To elucidate the molecular mechanisms underlying LAMP2-associated cardiomyopathy.
Main Methods:
- Introduction of an in-frame LAMP2 exon 6 deletion mutation into the mouse LAMP2 gene.
- Analysis of cardiac function, electrophysiology, and cardiomyocyte biology in mutant (L2Δ6) and wild-type mice.
- Utilized immunofluorescence, transmission electron microscopy, and gene/protein expression analyses.
Main Results:
- L2Δ6 mice exhibited reduced LAMP2 protein levels despite equivalent LAMP2 RNA.
- Mutant mice developed progressive left ventricular hypertrophy, dilatation, reduced systolic function, arrhythmias, and fibrosis.
- Cellular analysis revealed lysosomal mislocalization, autophagosome accumulation, and disrupted ultrastructure.
Conclusions:
- Impaired autophagy is a key factor in L2Δ6-induced cardiac hypertrophy and dysfunction.
- Transcriptional changes impact metabolism, calcium homeostasis, and cell survival, defining pathways in Danon disease cardiomyopathy.
- The L2Δ6 mouse model effectively recapitulates human LAMP2 cardiomyopathy, offering insights into disease mechanisms.
Abstract:
Background Human mutations in the X-linked lysosome-associated membrane protein-2 (LAMP2) gene can cause a multisystem Danon disease or a primary cardiomyopathy characterized by massive hypertrophy, conduction system abnormalities, and malignant ventricular arrhythmias. We introduced an in-frame LAMP2 gene exon 6 deletion mutation (denoted L2Δ6) causing human cardiomyopathy, into mouse LAMP2 gene, to elucidate its consequences on cardiomyocyte biology. This mutation results in in-frame deletion of 41 amino acids, compatible with presence of some defective LAMP2 protein. Methods and Results Left ventricular tissues from L2Δ6 and wild-type mice had equivalent amounts of LAMP2 RNA, but a significantly lower level of LAMP2 protein. By 20 weeks of age male mutant mice developed left ventricular hypertrophy which was followed by left ventricular dilatation and reduced systolic function. Cardiac electrophysiology and isolated cardiomyocyte studies demonstrated ventricular arrhythmia, conduction disturbances, abnormal calcium transients and increased sensitivity to catecholamines. Myocardial fibrosis was strikingly increased in 40-week-old L2Δ6 mice, recapitulating findings of human LAMP2 cardiomyopathy. Immunofluorescence and transmission electron microscopy identified mislocalization of lysosomes and accumulation of autophagosomes between sarcomeres, causing profound morphological changes disrupting the cellular ultrastructure. Transcription profile and protein expression analyses of L2Δ6 hearts showed significantly increased expression of genes encoding activators and protein components of autophagy, hypertrophy, and apoptosis. Conclusions We suggest that impaired autophagy results in cardiac hypertrophy and profound transcriptional reactions that impacted metabolism, calcium homeostasis, and cell survival. These responses define the molecular pathways that underlie the pathology and aberrant electrophysiology in cardiomyopathy of Danon disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification

